FDA FAERS Case Reports for Betamethasone/Calcipotriene Combination (4 Cases)

FDA FAERS Case Reports for Betamethasone/Calcipotriene Combination (4 Cases)

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
Original Request: 4 (four) cases was found during FAERS screening: 1) Case id: 24790848, suspect product active ingredient: Betamethasone Dipropionate\Calcipotriene, Reactions: Drug Ineffective. 2) Case id: 24790823, suspect product active ingredient: Betamethasone Dipropionate\Calcipotriene, Reactions: Blood Cholesterol Increased;Product Prescribing Issue;Hypertension;Drug Ineffective. 3) Case id: 24547956, suspect product active ingredient: Betamethasone\Calcipotriene, Reactions: Product Quality Issue;Application Site Discomfort;Application Site Pain. 4) Case id: 24547955, suspect product active ingredient: Betamethasone\Calcipotriene, Reactions: Pain;Off Label Use;Product Container Issue etc
Tags: Pharma, FAERS, 2025
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details